Feetkit
Strategic IP-first venture focused on the ankle/lower-leg as the missing node for on-body AI & communications. Multi-country patent family (US, CN, KR, CA, FR, DE, IT, UK) protected to 2035. Vision (concept stage): a removable ankle hub that routes comms, runs local AI, and enables dual-site biometrics—phone-optional when you want it. Core asset: anatomical-site claims + methods/systems for sensing, local compute, and connectivity orchestration at the ankle/lower-leg. Positioning: complements watches, rings, hearables, and glasses—creates an anatomical moat. Equation: ⌚ 🧦 → health intelligence + full-body compute + comms. Beachheads (with partners): • Health/MedTech: dual-site (wrist+ankle) for BP trends & DVT risk indicators. • XR/Platforms: offload power/compute/comms from head/wrist to ankle. • Security/Enterprise: gait-based auth & policy-driven uplink on private Wi-Fi/5G. Stage: pre-product, concept-stage (no internal team or prototype). Engagement: open to licensing, co-development, or strategic acquisition of the IP family.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
2
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Feetkit
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
- FC
Frédéric Charles
Founding CEO · General Business & Management
EmailPhone - FC
Frédéric Charles
- - · Other
EmailPhone
Showing 2 of 2 verified contacts
Top roles at Feetkit
2 distinct titles indexed · top 2 shown.
- 1- -
- 1founding ceo
Sign up to unlock all 2 contacts at Feetkit
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Feetkit
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.